Advertisement

Clinical Trials
Quanticate Expands Recruitment Services With Appointment of John Hunter as Recruitment Consultant for North America
Nov 23, 2009 12:15PM
Quanticate, a global biometricsclinical research organization , today announced that it has appointedJohn Hunter as Recruitment Consultant for the North American market.H...

Clinical Trials, Professional Services

Fitness & Nutrition
AmKor and Hengdian Group Signed Development & Commercialization License for Neu2000, a Drug Candidate for Multiple Diseases Including Stroke and Acute Myocardial Infarction, in China
Nov 23, 2009 12:00PM
AmKor (AmKor Pharma, Inc.) and HengdianGroup today announced the signing of licensingagreement for further development and commercialization of Neu2000 inChina.

Fitness & Nutrition, Nursing, Biotechnology, Clinical Trials

Consulting
Pending Key Developments Ahead for CytRx Corporation (NASDAQ: CYTR)
Nov 23, 2009 11:38AM
BioMedReports.Com, the news portal whichcovers Wall Street's biomedical sector and delivers financial andinvestment intelligence to a community of highly informed investo...

CytRx Corporation (CYTR), Consulting, Clinical Trials, Biotechnology

Medical Devices
Urodynamix Technologies Ltd. Provides Update on US Reimbursement
Nov 23, 2009 10:30AM
Urodynamix Technologies Ltd. today announced that the American Medical Association has published its 2010 Current Procedural Terminology (1) codes with additions, chang...

Motion Computing (URO), Medical Devices, Nursing, Biotechnology, Medical Supplies, Clinical Trials

Software
ValiMed(TM) MVS and ID2 Meth Scanner(TM) by CDEX Awarded GSA Contract Status
Nov 23, 2009 10:05AM
CDEX Inc. (www.cdexinc.com) and All Business Machines, Inc. ("ABMI")(www.abmicorp.com) announce that the ValiMed™ MVS (Medication ValidationSystem) and ID2 Meth Sca...

CDEX Inc. (CEXI), Software, Homeland Security, Biotechnology, Medical Supplies, Clinical Trials

Health
LabCorp is Scheduled to Present at the 21st Annual Piper Jaffray Health Care Conference
Nov 23, 2009 9:21AM
Laboratory Corporation of America® Holdings (LabCorp®) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the 21st Annual...

Laboratory Corporation of America(R) Holdings (LH), Health, AIDS, Biotechnology, Clinical Trials, Genetics, Hospitals, Pharmaceutical, Conference, Managed Care, New York, North Carolina, United States, North America

Stem Cells
StemCells, Inc. Initiates Landmark Trial Targeting “Communication Highway” of the Brain
Nov 23, 2009 9:01AM
StemCells, Inc. announced today that it has commenced patient recruitment for a Phase I clinical trial designed to test the safety and preliminary efficacy of its HuCNS-...

StemCells Inc. (STEM), Stem Cells, Education, University, Surgery, Health, Biotechnology, Clinical Trials, Genetics, Pharmaceutical, Product/Service, Research, FDA, Science, California, United States, North America

Biotechnology
Cleveland BioLabs Opens Enrollment of Second Safety Study for CBLB502
Nov 23, 2009 9:30AM
Cleveland BioLabs, Inc. todayannounced the opening of enrollment for the second human safety study forCBLB502, a drug under development for the treatment of Acute Radiat...

Cleveland BioLabs Inc. (CBLI), Biotechnology, Clinical Trials

Medical Devices
Daxor Announces Special Year-End Dividend
Nov 23, 2009 9:30AM
Daxor Corporation , a medicalinstrumentation and biotechnology company, today announced that The Boardof Directors has voted to declare a special year-end dividend of $1....

Daxor Corp. (DXR), Medical Devices, Biotechnology, Medical Supplies, Clinical Trials

Health
Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conference
Nov 23, 2009 8:41AM
Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial...

Health, Biotechnology, Clinical Trials, Oncology, Pharmaceutical, Conference, Product/Service, California, Massachusetts, United States, North America


About IBT PR Center
IBT PR Center is the leading provider of economically useful electronic real-time content and press releases.

IBT PR Center gathers nearly 5,000 stories a day from more than 20 publisher partners to create a variety of news products, delivered to top portal sites.

IBT PR Center receive select content from key sources which is further enhanced with stock tickers and an extended lexicon of relevant terms and tags. With a specialization in the financial news and content marketplace, IBT PR Center receives, enhances, combines and filters news and content received from national and international news agencies and publications.

advertisement

Popular Tags

advertisement